Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Daeduck Electronics (353200) – Decision on Cash/In-Kind Dividend / 2024-02-28 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-01-24 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Meritz | ADR Listing · Valuation Discount · Re-rating / 2026-04-23 RESEARCH
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Treasury Stock Acquisition / 2025-07-08 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Pre-announcement of Financial Results / 2025-07-15 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-03-17 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Decision on Cash and In-Kind Dividend / 2026-01-29 Semiconductors

[Disclosure] ALTEOGEN (196170) – Resolution on Submission of Agenda for Approval of Delisting / 2025-11-06

Posted on November 6, 2025August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ALTEOGEN resolved to submit an agenda for conditional delisting from the KOSDAQ market to the Extraordinary General Meeting of Shareholders (EGM) on December 8, 2025, for the purpose of transferring its listing to the KOSPI market.

📊 [Key Disclosure Details & Major Figures Summary]

  • Agenda Title: Resolution on Submission of Agenda for Approval of Delisting (Conditional KOSDAQ Delisting & KOSPI Transfer Listing)
  • Purpose of Delisting: Transfer listing to the KOSPI Market
  • EGM Date, Time & Location: December 08, 2025, at 09:00 / 1F Medium Conference Room, Daejeon Convention Center, 107 Expo-ro, Yuseong-gu, Daejeon
  • Board Resolution Date: November 06, 2025 (2 Outside Directors attended, Auditor attended)
  • Share Distribution Status (As of September 30, 2025):
    • Largest Shareholder (Soon-Jae Park) & Related Parties: 10,891,700 shares (20.36%)
    • 5% or Greater Shareholder (In-Woo Hyung): 2,700,000 shares (5.05%)
    • Other Shareholders: 39,914,088 shares (74.59%)
  • Future Plans: Upon approval at the EGM, the company plans to proceed with delisting from KOSDAQ conditional upon receiving listing approval for the KOSPI market

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of EGM Resolution and Subsequent KOSPI Listing Application Process

This disclosure formally announces the Board’s decision to table a conditional delisting agenda at the upcoming EGM to enable a market transfer to KOSPI. Verifying whether the resolution is approved at the EGM on December 8, 2025, and tracking the subsequent preliminary listing application submitted to the Korea Exchange (KRX) is essential because it allows investors to confirm the progress of the market relocation process. Detailed updates can be cross-checked in the upcoming Results of EGM disclosure and related filing announcements regarding the KOSPI listing review.

📢 Disclaimer & Source Notice

Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2025-11-06
Next Post: [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-06

Related Posts

  • [Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-22 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28 Semiconductors
  • [Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Subscription Results for Paid-in Capital Increase / 2025-07-08 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-06-17 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom Securities | Intensifying NAND Competition · DRAM Momentum · Target Price Cut / 2024-11-22 RESEARCH
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on General Meeting of Shareholders / 2025-08-06 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Decision on Capital Increase / 2025-06-25 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Change of Chief Executive Officer / 2024-10-18 Disclosures
  • [Disclosure] Celltrion (068270) – Decision on Acquisition of Treasury Shares / 2026-05-21 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-01-18 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Disclosure Related to Sustainability Report (Voluntary Disclosure) / 2025-06-27 Semiconductors
  • [Disclosure] Jeju Semiconductor (080220) – Decision on Issuance of Convertible Bonds (8th Series) / 2025-02-20 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme